We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

149 hedge funds and large institutions have $931M invested in Dr. Reddy's Laboratories in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

11% more capital invested

Capital invested by funds: $836M → $931M (+$94.6M)

6% more funds holding

Funds holding: 141149 (+8)

1.2% more ownership

Funds ownership: 65.21%66.41% (+1.2%)

25% less call options, than puts

Call options by funds: $513K | Put options by funds: $685K

26% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 58

Holders
149
Holders Change
+8
Holders Change %
+5.67%
% of All Funds
4.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
43
Reduced
58
Closed
15
Calls
$513K
Puts
$685K
Net Calls
-$172K
Net Calls Change
+$24K
Name Holding Trade Value Shares
Change
Change in
Stake
HDIM
76
Hanson & Doremus Investment Management
Vermont
$961K -$8.9K -1,125 -1%
GC
77
Guggenheim Capital
Illinois
$906K -$566K -71,490 -39%
VOYA Investment Management
78
VOYA Investment Management
Georgia
$904K -$1.9M -239,975 -69%
Jane Street
79
Jane Street
New York
$901K -$9.74M -1,230,285 -92%
RFC
80
Regions Financial Corp
Alabama
$835K +$197K +24,900 +32%
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
$757K +$142K +18,000 +24%
Macquarie Group
82
Macquarie Group
Australia
$741K +$273K +34,520 +62%
USAA
83
United Services Automobile Association
Texas
$693K +$277K +35,000 +71%
Ameriprise
84
Ameriprise
Minnesota
$667K +$609K +76,890 +1,768%
Citadel Advisors
85
Citadel Advisors
Florida
$655K +$632K +79,825 New
Nordea Investment Management
86
Nordea Investment Management
Sweden
$650K -$20.2K -2,555 -3%
SC
87
Saturna Capital
Washington
$615K
PA
88
Pinnacle Associates
New York
$585K -$3.17K -400 -0.6%
Neuberger Berman Group
89
Neuberger Berman Group
New York
$558K
Royal Bank of Canada
90
Royal Bank of Canada
Ontario, Canada
$512K +$386K +48,825 +359%
AAM
91
Advisors Asset Management
Colorado
$488K +$54.7K +6,910 +13%
Citigroup
92
Citigroup
New York
$478K -$18.9K -2,385 -4%
Comerica Bank
93
Comerica Bank
Texas
$460K -$43.7K -5,525 -9%
WAM
94
World Asset Management
Michigan
$438K -$137K -17,340 -25%
LG
95
Leuthold Group
Minnesota
$433K +$112K +14,120 +37%
CCMH
96
Cornerstone Capital Management Holdings
New York
$430K +$416K +52,500 New
WI
97
WHV Investments
California
$428K -$534K -67,450 -56%
Janus Henderson Group
98
Janus Henderson Group
United Kingdom
$417K -$304K -38,435 -43%
CA
99
Commerzbank Aktiengesellschaft
Germany
$408K +$387K +48,865 New
CANY
100
Caxton Associates (New York)
New York
$365K +$352K +44,500 New

RDY Hedge Fund Activity: Q4 2013 in Review

149 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2013, worth a combined $931M — up 11% from $836M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 43 added to existing stakes and 58 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $15.4M. The largest seller was Jane Street, cutting an estimated $9.74M.

  • 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2013, up from 141 in Q3 2013.
  • Funds reported $931M of Dr. Reddy's Laboratories stock for Q4 2013, up 11% quarter-over-quarter.
  • 23 funds opened new Dr. Reddy's Laboratories positions in Q4 2013 and 15 closed out, a net change of +8 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q4 2013 was Schroder Investment Management Group, an estimated $15.4M added.
  • The largest Dr. Reddy's Laboratories seller in Q4 2013 was Jane Street, an estimated $9.74M sold.

Based on aggregated 13F filings for Q4 2013.